Mobile

A study evaluating the effect of a chemotherapy regimen on the menstrual and ovarian functions of young breast cancer patients

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-000173-77

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

- Evaluate the impact of a cyclophosphamide-free regimen on the ovarian function recovery defined as menstrual resumption within 12 months following the end of chemotherapy - Evaluate the impact of a cyclophosphamide-free regimen on the development of ovarian failure defined as serum FSH >40 IU/L at 12 months following the end of chemotherapy

Critère d'inclusion

  • Primary breast cancer (adjuvant or neoadjuvant)

Liens